State Street’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.4K | Hold |
107,381
| – | – | ﹤0.01% | 4156 |
|
2025
Q1 | $30.6K | Hold |
107,381
| – | – | ﹤0.01% | 4157 |
|
2024
Q4 | $63K | Sell |
107,381
-400
| -0.4% | -$235 | ﹤0.01% | 4074 |
|
2024
Q3 | $48.1K | Hold |
107,781
| – | – | ﹤0.01% | 4111 |
|
2024
Q2 | $286K | Hold |
107,781
| – | – | ﹤0.01% | 3719 |
|
2024
Q1 | $295K | Hold |
107,781
| – | – | ﹤0.01% | 3780 |
|
2023
Q4 | $262K | Hold |
107,781
| – | – | ﹤0.01% | 3831 |
|
2023
Q3 | $218K | Sell |
107,781
-10,700
| -9% | -$21.6K | ﹤0.01% | 3915 |
|
2023
Q2 | $350K | Sell |
118,481
-664,129
| -85% | -$1.96M | ﹤0.01% | 3805 |
|
2023
Q1 | $1.96M | Buy |
782,610
+3,597
| +0.5% | +$8.99K | ﹤0.01% | 3350 |
|
2022
Q4 | $2.47M | Sell |
779,013
-3,141
| -0.4% | -$9.96K | ﹤0.01% | 3311 |
|
2022
Q3 | $2.32M | Sell |
782,154
-128,221
| -14% | -$381K | ﹤0.01% | 3374 |
|
2022
Q2 | $2.78M | Buy |
910,375
+82,801
| +10% | +$253K | ﹤0.01% | 3369 |
|
2022
Q1 | $11.2M | Buy |
827,574
+232,280
| +39% | +$3.14M | ﹤0.01% | 2764 |
|
2021
Q4 | $7.76M | Buy |
595,294
+110,041
| +23% | +$1.43M | ﹤0.01% | 3038 |
|
2021
Q3 | $4.55M | Buy |
485,253
+51,935
| +12% | +$487K | ﹤0.01% | 3287 |
|
2021
Q2 | $4.44M | Buy |
433,318
+220,967
| +104% | +$2.26M | ﹤0.01% | 3305 |
|
2021
Q1 | $3.91M | Buy |
212,351
+15,496
| +8% | +$285K | ﹤0.01% | 3158 |
|
2020
Q4 | $6.74M | Buy |
+196,855
| New | +$6.74M | ﹤0.01% | 2817 |
|